Kuiken Todd
Woodrow Wilson International Center for Scholars, One Woodrow Wilson Plaza, 1300 Pennsylvania Avenue, NW, Washington, DC, USA.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):111-118. doi: 10.1002/wnan.90. Epub 2010 Apr 20.
As medicine moves toward being able to predict what you will die from and when, nanomedicine is expected to enhance human capabilities and properties and promises the ability of health care professionals to diagnose, treat, and share medical information nearly instantaneously. It promises to deliver drugs directly to the source of the disease, i.e. tumor. This article examines the literature surrounding ethics associated with nanomedicine, and asks whether these ethical issues are new and unique. While opinions differ, this review concludes that none of the ethical questions surrounding nanomedicine are new or unique, and would hold true for any new medical device or medicine that was being evaluated. The real issue becomes public acceptance of nanomedicine and how much risk society is willing to accept with a new technology before it is proven effective and 'safe'. While ethical foresight can prove effective in forecasting potential problems, in reality, ethics may not be capable of evaluating such a technology that has yet proven effective in all it has promised.
